← Leaderboards
Livio Pellizzoni
Columbia University Health Sciences
$13,515,447
Attributed
$13,515,447
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,515,447 · 11
By mechanism
R01$10,244,664 · 4
R21$3,270,783 · 7
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- George Z Mentis$12,085,277
- Umrao Monani$8,251,575
- Jacqueline Montes$1,184,721
- Thomas M. Jessell$11,851,221
- Sarah R Tisdale$127,140
Others in their field
Top investigators on “Spinal Muscular Atrophy”
- Michael Watson · American College Of Medical Genetics$17,498,971
- Diane E Merry · Thomas Jefferson University$16,537,310
- Arthur H.m Burghes · Ohio State University$13,366,018
- Albert R La Spada · University Of Washington$13,268,603
- Charlotte Jane Sumner · Johns Hopkins University$12,001,647
- A. Gregory Matera · Case Western Reserve University$10,937,514
Research focus
Spinal Muscular AtrophyMotor NeuronsSmn Protein (Spinal Muscular Atrophy)Mouse ModelLinkNeurodegenerative DisordersPathway InteractionsMediatingFunctional DisorderPhenotypeMotor Neuron DegenerationPathologyInsightGeneticMolecularSkeletal Muscle WastingMotorDesignGenesEventSeverity Of IllnessNeuron LossRestorationInherited
Grant awards (37)
RNA-Mediated Mechanisms of Motor System Dysfunction in Spinal Muscular Atrophy$584,920
R01 · FY2025 · NS · contact PI
RNA-Mediated Mechanisms of Motor System Dysfunction in Spinal Muscular Atrophy$649,910
R01 · FY2024 · NS · contact PI
Essential role of Stasimon in motor circuit development and disease$564,390
R01 · FY2024 · NS · contact PI
Mechanisms and Therapeutic Targeting of Motor Neuron Death in SMA$458,129
R01 · FY2024 · NS · contact PI
Essential role of Stasimon in motor circuit development and disease$581,844
R01 · FY2023 · NS · contact PI
Mechanisms and therapeutic targeting of motor neuron death in SMA$472,299
R01 · FY2023 · NS · contact PI
Essential role of Stasimon in motor circuit development and disease$581,844
R01 · FY2022 · NS · contact PI
Mechanisms and therapeutic targeting of motor neuron death in SMA$472,299
R01 · FY2022 · NS · contact PI
Essential role of Stasimon in motor circuit development and disease$581,844
R01 · FY2021 · NS · contact PI
Mechanisms and therapeutic targeting of motor neuron death in SMA$472,299
R01 · FY2021 · NS · contact PI
RNA-Mediated Mechanisms of Motor System Dysfunction in Spinal Muscular Atrophy$408,886
R01 · FY2021 · NS · contact PI
Essential role of Stasimon in motor circuit development and disease$581,844
R01 · FY2020 · NS · contact PI
Mechanisms and therapeutic targeting of motor neuron death in SMA$472,299
R01 · FY2020 · NS · contact PI
RNA-mediated mechanisms of motor system dysfunction in spinal muscular atrophy$408,886
R01 · FY2020 · NS · contact PI
RNA-mediated mechanisms of motor system dysfunction in spinal muscular atrophy$17,395
R01 · FY2020 · NS · contact PI
RNA-mediated mechanisms of motor system dysfunction in spinal muscular atrophy$408,886
R01 · FY2019 · NS · contact PI
RNA-mediated mechanisms of motor system dysfunction in spinal muscular atrophy$408,886
R01 · FY2018 · NS · contact PI
The Role of p38 MAPK Activation in Spinal Muscular Atrophy$200,000
R21 · FY2018 · NS · contact PI
RNA-mediated mechanisms of motor system dysfunction in spinal muscular atrophy$408,886
R01 · FY2017 · NS · contact PI
The Role of p38 MAPK Activation in Spinal Muscular Atrophy$240,000
R21 · FY2017 · NS · contact PI
SMN dysfunction in FUS-dependent ALS$200,000
R21 · FY2017 · NS · contact PI
SMN dysfunction in FUS-dependent ALS$240,000
R21 · FY2016 · NS · contact PI
Small chemical modulators of SMN biology as candidate therapeutics for SMA$320,000
R21 · FY2015 · NS · contact PI
A genome-wide phenotypic screen for modifiers of SMN expression and function$200,000
R21 · FY2015 · NS · contact PI
SMN Control of snRNP Biogenesis: Role in RNA Splicing and Motor Neuron Survival$341,692
R01 · FY2014 · NS · contact PI
Small chemical modulators of SMN biology as candidate therapeutics for SMA$320,000
R21 · FY2014 · NS · contact PI
A genome-wide phenotypic screen for modifiers of SMN expression and function$240,000
R21 · FY2014 · NS · contact PI
SMN Control of snRNP Biogenesis: Role in RNA Splicing and Motor Neuron Survival$333,064
R01 · FY2013 · NS · contact PI
Role of Stasimon Dysfunction in Spinal Muscular Atrophy$193,000
R21 · FY2013 · NS · contact PI
SMN Control of snRNP Biogenesis: Role in RNA Splicing and Motor Neuron Survival$345,144
R01 · FY2012 · NS · contact PI
Role of Stasimon Dysfunction in Spinal Muscular Atrophy$240,000
R21 · FY2012 · NS · contact PI
SMN Control of snRNP Biogenesis: Role in RNA Splicing and Motor Neuron Survival$345,144
R01 · FY2011 · NS · contact PI
A Functional Cell-Based Screen for Potential SMA Therapeutic Compounds$236,670
R21 · FY2011 · NS · contact PI
SMN Control of snRNP Biogenesis: Role in RNA Splicing and Motor Neuron Survival$343,874
R01 · FY2010 · NS · contact PI
A Functional Cell-Based Screen for Potential SMA Therapeutic Compounds$201,250
R21 · FY2010 · NS · contact PI
Noncoding RNA targets of the spinal muscular atrophy protein$199,238
R21 · FY2010 · NS · contact PI
Noncoding RNA targets of the spinal muscular atrophy protein$240,625
R21 · FY2009 · NS · contact PI